FatimaAhmad(Barbar)Barbar-SmileyMDMPH
Pediatric Rheumatology • Thousand Oaks, CAJuvenile Rheumatoid Arthritis and Related Rheumatology, Pediatric Lupus and Related Rheumatology
Clinical Research Medical Director
Dr. Barbar-Smiley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Amgen - Headquarters
1 Amgen Center Dr
Thousand Oaks, CA 91320
Summary
- Dr. Fatima Barbar-Smiley, a pediatric rheumatologist and clinical researcher with 20+ years' experience managing complex rheumatologic conditions in children. As a Clinical Research Medical Director she executes clinical trials in the pharmaceutical industry's inflammation therapeutic area, contributing to new therapeutic options development for rheumatologic patients.
Education & Training
Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 2014 - 2016
The Ohio State UniversityMPH, Clinical Translational Science, 2012 - 2014
The Ohio State UniversityPublic Health, Clinical Translational Science , 2012 - 2014- Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Rheumatology, 2011 - 2014
Beirut Arab University Faculty of MedicineClass of 2001
Certifications & Licensure
OH State Medical License 2011 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Rheumatology
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY SLOAN SCHOOL OF MANAGEMENTArtificial Intelligence in Pharma and Biotech
Clinical Trials
- Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV. Start of enrollment: 2024 Jul 31
- Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease Start of enrollment: 2021 Sep 09
- Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) Start of enrollment: 2020 Feb 19
Publications & Presentations
PubMed
- Uveitis treatment in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: response to tumour necrosis factor inhibitors.Mona M Riskalla, Fatima A Barbar-Smiley, Nicholas A Marka, Melissa A Lerman
Clinical and Experimental Rheumatology. 2024-12-20 - Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research.Margaret H Chang, Fatima Barbar-Smiley, Shoghik Akoghlanian, Joanne Drew, Sheila T Angeles-Han
Pediatric Rheumatology Online Journal. 2024-10-07 - Key data elements for a successful pediatric rheumatology virtual visit: a survey within the PR-COIN network.Y Ingrid Goh, Meghan E Ryan, Shoghik Akoghlanian, Rajdeep Pooni, Julia G Harris
Frontiers in Pediatrics. 2024-01-01
Books/Book Chapters
Professional Memberships
- Fellow
- Fellow
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
